Market Herald logo

Subscribe

Be the first with the news that moves the market

CropLogic Limited has announced the increase in its industrial hemp trial farm in Oregon, USA.

This increase will see Industrial Hemp move from 150 to 500 acres to further integrate its agronomy, study of crops and soils, and agtech expertise.

It will also allow for its subsidiary, LogicalCropping, to evaluate data for different growing conditions such as soil type, land contours and elevation to optimise crop yields.

CropLogic will use drones, aerial imagery and grower view to apply its agronomy expertise. Total production is estimated to be between 800,000 and 1,100,000 pounds of industrial hemp across the 500 acres.

CropLogic CEO James Cooper-Jones hopes the production will keep increasing.

“We feel the varying growing environments presents an opportunity for CropLogic to further vertically integrate its agronomy and agtech expertise,” he said.

Industrial hemp is used for any industrial (non-drug) use such as fabrics, biodegradable plastics, construction, health food and fuel.

With this trial CropLogic will also release 75,000,000 shares to sophisticated and institutional investors to raise $3 million at $0.04 per share.

It will be undertaken in two phases with the first one to release 42,490,411 shares and raise $1.7 million. The second phase consists of 31,509,589 shares to raise $1.3 million but will be subject to approval at the next general meeting in May 2019.

Please find the announcement here

CLI by the numbers
More From The Market Herald

" Kelsian Group (ASX:KLS) sells East London bus operation for £20m

Tourism and bus company Kelsian Group (ASX:KLS) agrees to sell its East London bus operations to…
The Market Herald Video

" Next Science’s (ASX:NXS) CEO submits resignation

Next Science’s (ASX:NXS) CEO has announced her intention to retire before June 30, 2023.
The Market Herald Video

" Titomic (ASX:TTT) sells first Titomic D523 system in Asia Pacific

Titomic (ASX:TTT) has sold its first Titomic D523 system through the company's Australian branch to D&C…
The Market Herald Video

" Race Oncology (ASX:RAC) completes first-phase Zantrene leukaemia trial

Cancer treatment company Race Oncology (ASX:RAC) has completed the latest stage of its first-phase trial for…